Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

[Antibiotic therapy in dental practice].

Verduin CM.

Ned Tijdschr Tandheelkd. 2019 Oct;126(10):483-490. doi: 10.5177/ntvt.2019.10.19084. Dutch.

PMID:
31613276
2.

Successful Debridement of a Knee Joint Prosthesis Infected with Listeria Monocytogenes. Case Report and Review of Current Literature.

van der Weegen W, Verduin CM, Graumans M, Hoekstra HJ.

J Bone Jt Infect. 2018 Oct 4;3(4):203-206. doi: 10.7150/jbji.28146. eCollection 2018.

3.

Sepsis caused by acute phlegmonous gastritis based on a group A Streptococcus.

Ramphal W, Mus M, Nuytinck HKS, van Heerde MJ, Verduin CM, Gobardhan PD.

J Surg Case Rep. 2018 Aug 4;2018(8):rjy188. doi: 10.1093/jscr/rjy188. eCollection 2018 Aug.

4.

Human resources required for antimicrobial stewardship teams: a Dutch consensus report.

Ten Oever J, Harmsen M, Schouten J, Ouwens M, van der Linden PD, Verduin CM, Kullberg BJ, Prins JM, Hulscher MEJL; SWAB Working Group on Antimicrobial Stewardship.

Clin Microbiol Infect. 2018 Dec;24(12):1273-1279. doi: 10.1016/j.cmi.2018.07.005. Epub 2018 Jul 20.

PMID:
30036665
5.

Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.

Crobach MJT, Duszenko N, Terveer EM, Verduin CM, Kuijper EJ.

J Clin Microbiol. 2018 Feb 22;56(3). pii: e01316-17. doi: 10.1128/JCM.01316-17. Print 2018 Mar.

6.

Detection of Clostridium difficile in Feces of Asymptomatic Patients Admitted to the Hospital.

Terveer EM, Crobach MJ, Sanders IM, Vos MC, Verduin CM, Kuijper EJ.

J Clin Microbiol. 2017 Feb;55(2):403-411. doi: 10.1128/JCM.01858-16. Epub 2016 Nov 16.

7.

[A blood culture containing coagulase-negative staphylococci: not always due to contamination].

Wagenaar EC, van Wijngaarden P, Verduin CM, Beelen D, van Etten RW.

Ned Tijdschr Geneeskd. 2016;160:A9336. Dutch.

PMID:
27781969
8.

Current evidence on hospital antimicrobial stewardship objectives: a systematic review and meta-analysis.

Schuts EC, Hulscher MEJL, Mouton JW, Verduin CM, Stuart JWTC, Overdiek HWPM, van der Linden PD, Natsch S, Hertogh CMPM, Wolfs TFW, Schouten JA, Kullberg BJ, Prins JM.

Lancet Infect Dis. 2016 Jul;16(7):847-856. doi: 10.1016/S1473-3099(16)00065-7. Epub 2016 Mar 3. Review. Erratum in: Lancet Infect Dis. 2016 Jul;16(7):768.

PMID:
26947617
9.

Diagnosis and management of aspergillosis in the Netherlands: a national survey.

Lestrade PP, Meis JF, Arends JP, van der Beek MT, de Brauwer E, van Dijk K, de Greeff SC, Haas PJ, Hodiamont CJ, Kuijper EJ, Leenstra T, Muller AE, Oude Lashof AM, Rijnders BJ, Roelofsen E, Rozemeijer W, Tersmette M, Terveer EM, Verduin CM, Wolfhagen MJ, Melchers WJ, Verweij PE.

Mycoses. 2016 Feb;59(2):101-7. doi: 10.1111/myc.12440. Epub 2015 Dec 9.

PMID:
26648179
10.

Coccidioidomycosis infection of a total knee arthroplasty in a nonendemic region.

Austen S, van der Weegen W, Verduin CM, van der Valk M, Hoekstra HJ.

J Arthroplasty. 2013 Feb;28(2):375.e13-5. doi: 10.1016/j.arth.2012.05.006. Epub 2012 Jul 17.

PMID:
22810005
11.

The use of Raman spectroscopy in the epidemiology of methicillin-resistant Staphylococcus aureus of human- and animal-related clonal lineages.

Wulf MW, Willemse-Erix D, Verduin CM, Puppels G, van Belkum A, Maquelin K.

Clin Microbiol Infect. 2012 Feb;18(2):147-52. doi: 10.1111/j.1469-0691.2011.03517.x. Epub 2011 Aug 19.

12.

Infection and colonization with methicillin resistant Staphylococcus aureus ST398 versus other MRSA in an area with a high density of pig farms.

Wulf MW, Verduin CM, van Nes A, Huijsdens X, Voss A.

Eur J Clin Microbiol Infect Dis. 2012 Jan;31(1):61-5. doi: 10.1007/s10096-011-1269-z. Epub 2011 May 1.

PMID:
21533878
13.

First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007.

Wulf MW, Markestein A, van der Linden FT, Voss A, Klaassen C, Verduin CM.

Euro Surveill. 2008 Feb 28;13(9). pii: 8051. No abstract available.

14.

[Invasive pneumococcal infection in 5 newborns, 1996-2004].

Marcus KA, Verduin CM, Halbertsma FJ.

Ned Tijdschr Geneeskd. 2007 Nov 10;151(45):2527-30. Dutch.

PMID:
18062598
15.

High-throughput amplification fragment length polymorphism (htAFLP) analysis identifies genetic lineage markers but not complement phenotype-specific markers in Moraxella catarrhalis.

Hays JP, Gorkink R, Simons G, Peeters JK, Eadie K, Verduin CM, Verbrugh H, van Belkum A.

Clin Microbiol Infect. 2007 Jan;13(1):55-62.

16.

Moraxella catarrhalis is only a weak activator of the mannose-binding lectin (MBL) pathway of complement activation.

Hays JP, Ott A, Verduin CM, van Belkum A, Kuipers S.

FEMS Microbiol Lett. 2005 Aug 15;249(2):207-9.

17.

A novel plasmid (pEMCJH03) isolated from moraxella catarrhalis possibly useful as a cloning and expression vector within this species.

Hays JP, Eadie K, Verduin CM, Verbrugh H, van Belkum A.

Plasmid. 2005 May;53(3):263-8. Epub 2004 Dec 22.

PMID:
15848230
18.

Pneumococcal vaccination does not affect the genetic diversity of Moraxella catarrhalis isolates in children.

Hays JP, Eadie K, Veenhoven R, Verduin CM, Verbrugh H, van Belkum A.

Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):801-3. No abstract available.

PMID:
15449099
19.

Changes in genetic types and population dynamics of Moraxella catarrhalis in hospitalized children are not associated with an exacerbation of existing disease.

Hays JP, Eadie K, Verduin CM, Hazelzet J, Verbrugh H, van Belkum A.

J Med Microbiol. 2003 Sep;52(Pt 9):815-20.

PMID:
12909660
20.

A case of Mycoplasma hominis meningo-encephalitis in a full-term infant: rapid recovery after start of treatment with ciprofloxacin.

Wolthers KC, Kornelisse RF, Platenkamp GJJM, Schuurman-van der Lem MI, van der Schee C, Hartwig NG, Verduin CM.

Eur J Pediatr. 2003 Jul;162(7-8):514-516. doi: 10.1007/s00431-003-1219-6. Epub 2003 May 10.

PMID:
12740695
21.
22.

Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.

de Hoog M, Mouton JW, Schoemaker RC, Verduin CM, van den Anker JN.

Clin Pharmacol Ther. 2002 May;71(5):349-58.

PMID:
12011820
23.

Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial.

Koning S, van Suijlekom-Smit LW, Nouwen JL, Verduin CM, Bernsen RM, Oranje AP, Thomas S, van der Wouden JC.

BMJ. 2002 Jan 26;324(7331):203-6.

24.

Moraxella catarrhalis: from emerging to established pathogen.

Verduin CM, Hol C, Fleer A, van Dijk H, van Belkum A.

Clin Microbiol Rev. 2002 Jan;15(1):125-44. Review.

25.

Cellular membrane associated mucins in artificial urine as mediators of crystal adhesion: an in vitro enterocystoplasty model.

Mathoera RB, Kok DJ, Visser WJ, Verduin CM, Nijman RJ.

J Urol. 2001 Dec;166(6):2329-36.

PMID:
11696777
26.

Distinguishing species of the Burkholderia cepacia complex and Burkholderia gladioli by automated ribotyping.

Brisse S, Verduin CM, Milatovic D, Fluit A, Verhoef J, Laevens S, Vandamme P, Tümmler B, Verbrugh HA, van Belkum A.

J Clin Microbiol. 2000 May;38(5):1876-84.

27.

Complement-resistant Moraxella catarrhalis forms a genetically distinct lineage within the species.

Verduin CM, Kools-Sijmons M, van der Plas J, Vlooswijk J, Tromp M, van Dijk H, Banks J, Verbrugh H, van Belkum A.

FEMS Microbiol Lett. 2000 Mar 1;184(1):1-8.

28.

Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods.

van Pelt C, Verduin CM, Goessens WH, Vos MC, Tümmler B, Segonds C, Reubsaet F, Verbrugh H, van Belkum A.

J Clin Microbiol. 1999 Jul;37(7):2158-64.

29.

Moraxella catarrhalis in acute laryngitis: infection or colonization?

Hol C, Schalén C, Verduin CM, Van Dijke EE, Verhoef J, Fleer A, Van Dijk H.

J Infect Dis. 1996 Sep;174(3):636-8.

PMID:
8769627
30.

Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.

Hol C, Verduin CM, Van Dijke EE, Verhoef J, Fleer A, van Dijk H.

FEMS Immunol Med Microbiol. 1995 Jun;11(3):207-11.

PMID:
7581272
31.

Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Verduin CM, Hol C, Van Dijke E, Faber JA, Jansze M, Verhoef J, Van Dijk H.

Clin Diagn Lab Immunol. 1995 May;2(3):365-8.

32.

Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.

Hol C, Van Dijke EE, Verduin CM, Verhoef J, van Dijk H.

J Infect Dis. 1994 Dec;170(6):1613-6.

PMID:
7996007
34.

Complement resistance in Branhamella (Moraxella) catarrhalis.

Hol C, Verduin CM, van Dijke E, Verhoef J, van Dijk H.

Lancet. 1993 May 15;341(8855):1281. No abstract available.

PMID:
8098421
35.

Observations on constitutional resistance to infection.

Verduin CM, Hol C, Bootsma HJ, Verhoef J, van Dijk H.

Immunol Today. 1993 Jan;14(1):44-5. No abstract available.

PMID:
8442864

Supplemental Content

Loading ...
Support Center